Item

Impact of bone protecting agents (BPA) on the efficacy and safety of enzalutamide vs. combination of radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): sub-goup analysis from EORTC-GUCG 1333/PEACE-3, an EORTC/CTI/CUOG/LACOG/UNICANCER randomized phase III study

Saad, F.
; 
Gillessen, S.
; 
Choudhury, A.
; 
Gallardo, E.
; 
Soares, A.
; 
Loriot, Y.
; 
McDermott, R.
; 
Rodriguez-Vida, A.
; 
Velho, P. I.
; 
Nole, F.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Saad, F.
Gillessen, S.
Choudhury, A.
Gallardo, E.
Soares, A.
Loriot, Y.
McDermott, R.
Rodriguez-Vida, A.
Velho, P. I.
Nole, F.
Cruz, F.
Roumeguere, T.
Daugaard, G.
Yamamura, R.
Pouliot, F.
Lecouvet, F.
Hamilou, Z.
Fournier, B.
Coens, C.
Poncet, C.
Tombal, B.
Affiliation
Ctr Hosp Univ Montreal, Dept Surg, Montreal, PQ, Canada Oncol Inst Southern Switzerland, Dept Med Oncol, Bellinzona, Switzerland Christie NHS Fdn Trust, Dept Med Oncol, Manchester, England Tauli Hosp Univ, Dept Med Oncol, Sabadell, Spain Hosp Israelita Albert Einstein, Dept Med Oncol, Sao Paulo, Brazil Inst Gustave Roussy, Dept Med Oncol, Paris, France Tallaght Univ Hosp, Dept Med Oncol, Dublin, Ireland Hosp Del Mar, Dept Med Oncol, Barcelona, Spain Hosp Moinhos Vento, Dept Med Oncol, Porto Alegre, Brazil European Inst Oncol IRCCS, Div Urogenital & Head & Neck Tumors, Milan, Italy Inst Brasileiro Controle Canc, Dept Med Oncol, Sao Paulo, Brazil Hop Erasme, Dept Med Oncol, HUB, Brussels, Belgium Rigshosp, Dept Med Oncol, Copenhagen, Denmark Beneficencia Portuguesa Sao Paulo, Dept Med Oncol, Sao Paulo, Brazil Ctr Hospi Univ Laval, Dept Med Oncol, Quebec, Belgium Clin Univ St Luc, Dept Radiol, Brussels, Belgium Ctr Hosp Univ Montreal, Dept Med Oncol, Montreal, PQ, Canada European Org Res Treatment Canc, Med Dept, Brussels, Belgium European Org Res Treatment Canc, Dept Stat, Brussels, Belgium Clin Univ St Luc, Dept Urol, Brussels, Belgium
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Saad F, Gillessen S, Choudhury A, Gallardo E, Soares A, Loriot Y, et al. Impact of bone protecting agents (BPA) on the efficacy and safety of enzalutamide vs. combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): Sub-goup analysis from EORTC-GUCG 1333/PEACE-3, an EORTC/CTI/CUOG/LACOG/UNICANCER randomized phase III study. EUROPEAN UROLOGY. 2025 MAR;87. PubMed PMID: WOS:001578797300024. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627810
Embedded videos